| # | Drug | Count |
|---|---|---|
| 0 | AZATHIOPRINE | 31 |
| 1 | PREDNISONE | 29 |
| 2 | CYCLOPHOSPHAMIDE | 24 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 24 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 24 |
| 5 | METHOTREXATE SODIUM | 24 |
| 6 | RITUXIMAB | 24 |
| 7 | METHOTREXATE | 23 |
| 8 | PREDNISOLONE | 18 |
| 9 | PREDNISOLONE ORAL | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELAPEGADEMASE-LVLR | 1 | 0.0033 |
| 1 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| 2 | OMEPRAZOLE 20MG | 1 | 0.0009 |
| 3 | STREPTOMYCIN | 1 | 0.0009 |
| 4 | BLEOMYCIN SULFATE | 9 | 0.0009 |
| 5 | MESNA INJECTION | 7 | 0.0008 |
| 6 | MESNA | 7 | 0.0008 |
| 7 | INTERFERON GAMMA-1B | 1 | 0.0007 |
| 8 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 9 | AZATHIOPRINE | 31 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 51 |
| 1 | Purine Antimetabolite [EPC] | 31 |
| 2 | Alkylating Drug [EPC] | 24 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 24 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 23 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 6 | Anti-epileptic Agent [EPC] | 12 |
| 7 | Mood Stabilizer [EPC] | 12 |
| 8 | Topoisomerase Inhibitor [EPC] | 10 |
| 9 | Proton Pump Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma [EPC] | 1 | 0.0007 |
| 1 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 2 | Purine Antimetabolite [EPC] | 31 | 0.0003 |
| 3 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |
| 7 | Glinide [EPC] | 1 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 24 | 0.0001 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |